CA
NZ
UK
AU
IND
US
The False Claims Act, originally enacted during the Civil War to combat contractor fraud against the federal government, has in the modern era become the primary legal vehicle for enforcement against healthcare fraud. Its qui tam provision allows private individuals, typically current or former …
Merck's Keytruda has established itself as the defining immuno-oncology therapy of the past decade through a combination of broad efficacy, a first-mover advantage that allowed it to establish itself as the standard of care across multiple tumour types, and an extraordinary clinical development programme …
Key HighlightsGoldman Sachs set a new price target on Biogen, reflecting revised assumptions about the commercial trajectory of its Alzheimer's diseaseFranchisefollowing the latest clinical and market data.Biogen's Alzheimer's programme, centred on the amyloid-targeting antibody Leqembi developed with Eisai, represents one of the most commercially …
The development of oral versions of GLP-1 receptor agonist medications, which have demonstrated transformative efficacy in obesity treatment primarily in injectable formats, represents one of the largest commercial opportunities in pharmaceutical history. Injectables have been the dominant format for GLP-1 therapy since the category …
Whirlpool's products, including washing machines, refrigerators, dishwashers, and ovens, occupy a specific position in the consumer spending hierarchy that makes the company's demand data a useful early warning indicator for broader consumer health. Appliance purchases are discretionary in timing even when they are not …
The sharpReversalin shares of TransMedics Group, Inc. (NASDAQ: TMDX) highlights a familiar dynamic unfolding across high-growth healthcare technology companies: investors remain willing to tolerate temporary earnings pressure when long-term structural growth remains intact.
Eli Lilly and Company (NYSE: LLY) is one of the most-watched USLarge-Cap Stocksafter a Q1 2026 earnings report that smashed expectations, driven by record demand for GLP-1 medicines Mounjaro and Zepbound. With a marketCapitalizationof about $946.37 billion, LLY remains the world's largest pharmaceutical company …
Johnson & Johnson (NYSE: JNJ) remains one of the most stable US large-cap healthcare stocks. With a marketCapitalizationof about $545.74 billion, JNJ continues to anchor the US pharma and medical devices sectors. Shares slipped 1.77% on the snapshot day amid broader market consolidation, but …
Intuitive Surgical, Inc. (Nasdaq: ISRG) is one of the most-watched US large-cap medical device stocks. With a marketCapitalizationof about $149.15 billion, ISRG continues to lead the robotic surgery sector. Shares fell 1.62%.
AbbVie Inc. (NYSE:ABBV) remains one of the most-watched US large-cap pharmaceutical stocks after a Q1 2026Earningsprint that confirmed the company's post-Humira transition is delivering. With a marketCapitalizationof about $371.72 billion, ABBV continues to lead in immunology. Shares slipped 0.18% on the snapshot day.
Please wait processing your request...